Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank.

Pubmed ID: 35946401

Pubmed Central ID: PMC7613487

Journal: Circulation research

Publication Date: Sept. 2, 2022

Affiliation: Division of Cardiology (J.A.C.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.

MeSH Terms: Humans, Male, Longitudinal Studies, Prospective Studies, Diabetes Mellitus, Type 2, Brachial Artery, Vascular Stiffness, Biological Specimen Banks, Pulse Wave Analysis, Glucose

Grants: N01HC25195, R01 AG028321, R01 HL076784, K23 HL133843, R01 HL121510, R01 HL142983, HHSN268201500001I, R03 HL146874, P01 HL094307, R01 HL104106, R56 HL136730, R01 AG058969, HHSN268201500001C, 75N92019D00031, R01 HL060040, K24 AG070459, R01 HL155599, U01 TR003734, R01 HL077447, R01 HL153646, MC_UU_00002/7, U01 HL160277, R01 HL070100, R01 HL126136, R01 AG074989, MC_QA137853, MC_PC_17228, R01 HL071039, U24 DK060990, R01 HL157108, R01 HL157264, R01 DK123104, R01 HL080124, MR/S019669/1, R33 HL146390

Authors: Rahman M, Chirinos JA, Burgess S, Townsend RR, Cohen JB, Mitchell GF, Gill D, Hanff TC, Ramachandran VS, Mutalik KM

Cite As: Cohen JB, Mitchell GF, Gill D, Burgess S, Rahman M, Hanff TC, Ramachandran VS, Mutalik KM, Townsend RR, Chirinos JA. Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank. Circ Res 2022 Sep 2;131(6):545-554. Epub 2022 Aug 10.

Studies:

Abstract

BACKGROUND: Microvascular damage from large artery stiffness (LAS) in pancreatic, hepatic, and skeletal muscles may affect glucose homeostasis. Our goal was to evaluate the association between LAS and the risk of type 2 diabetes using prospectively collected, carefully phenotyped measurements of LAS as well as Mendelian randomization analyses. METHODS: Carotid-femoral pulse wave velocity (CF-PWV) and brachial and central pulse pressure were measured in 5676 participants of the FHS (Framingham Heart Study) without diabetes. We used Cox proportional hazards regression to evaluate the association of CF-PWV and pulse pressure with incident diabetes. We subsequently performed 2-sample Mendelian randomization analyses evaluating the associations of genetically predicted brachial pulse pressure with type 2 diabetes in the UKBB (United Kingdom Biobank). RESULTS: In FHS, individuals with higher CF-PWV were older, more often male, and had higher body mass index and mean arterial pressure compared to those with lower CF-PWV. After a median follow-up of 7 years, CF-PWV and central pulse pressure were associated with an increased risk of new-onset diabetes (per SD increase, multivariable-adjusted CF-PWV hazard ratio, 1.36 [95% CI, 1.03-1.76]; <i>P</i>=0.030; central pulse pressure multivariable-adjusted CF-PWV hazard ratio, 1.26 [95% CI, 1.08-1.48]; <i>P</i>=0.004). In United Kingdom Biobank, genetically predicted brachial pulse pressure was associated with type 2 diabetes, independent of mean arterial pressure (adjusted odds ratio, 1.16 [95% CI, 1.00-1.35]; <i>P</i>=0.049). CONCLUSIONS: Using prospective cohort data coupled with Mendelian randomization analyses, we found evidence supporting that greater LAS is associated with increased risk of developing diabetes. LAS may play an important role in glucose homeostasis and may serve as a useful marker of future diabetes risk.